Rachel Wisniewski for STAT

STAT+ | For pancreatic cancer patients, an exciting drug can feel out of reach

Positive results for daraxonrasib have taken the oncology world by storm. With so much interest and demand, patients are scrambling to get access.

By Ed Silverman

STAT+ | Trump administration to strip job protections of top NIH officials, grants staff

President Trump issued an executive order that science officials have feared will make the grants process more susceptible to political whims.

By Anil Oza

STAT+ | After hospitals, patients get a turn to bring AI into the doctor’s office

AI scribes were the first large-scale application of artificial intelligence in health care. Now developers are pitching them as diligent note-takers for patients.

By Katie Palmer

Maria Fabrizio for STAT

Male puberty is understudied — but when it starts may predict long-term health risks

Researchers say puberty timing may predict men's risk of heart disease, diabetes, depression, and may even explain shorter male lifespans.

By Ashleigh N. DeLuca

STAT+ | Does Revolution Medicines’ pancreatic cancer drug have even greater potential?

The FDA's former top cancer drug regulator, Rick Pazdur, has some ideas on how to find out how else daraxonrasib might be used.

By Adam Feuerstein

Opinion: Lawmakers promised cancer patients would be protected from Medicaid cuts. Now CMS says otherwise

Medicaid work requirement interim final rule could force cancer patients, including those in active treatment, to work the hours as a healthy person.

By Gwen Nichols

What happens at a longevity festival?

Human lifespan extension has moved from science fiction to big business. STATus Report host Alex Hogan looks at the people you find at a longevity festival.

By Alex Hogan

Opinion: Grail’s multi-cancer early detection trial was negative. But as an oncologist, I see more to this story

Technical and methodological challenges got in the way of clear results and definitive conclusions in Grail’s multi-cancer early detection test.

By Sana Raoof